Last updated on September 2018

Extending the Time for Thrombolysis in Emergency Neurological Deficits

Brief description of study

The primary hypothesis being tested in this trial is that ischaemic stroke patients selected with significant penumbral mismatch (measured by MRI criteria) at 3 - 9 hours post onset of stroke will have improved clinical outcomes when given intravenous tissue plasminogen activator (tPA) compared to placebo.

Clinical Study Identifier: NCT00887328

Contact Investigators or Research Sites near you

Start Over

Jon Sturm

Gosford Hospital
Kanwal, Australia

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.